Exec Chat: Sequana Medical Pursues Dual Device-Drug Strategy For Fluid Overload

 
• By Barnaby Pickering

Speaking to Medtech Insight, Sequana Medical’s CEO discussed the company’s two technologies for combating fluid overload whilst explaining that, sometimes, chasing approval as a drug can be the best way to ensure easy market access.

Water and sodium: the two things Sequana Medical are developing technologies to remove • Source: Shutterstock

More from Clinical Trials

More from R&D